Article may be outdated

This article is 23 days old. Some details may have changed since publication.

Medical Xpress·4 min read·hard

New strategy could prevent T cell exhaustion and boost immunotherapy

J
Jim Stallard
New strategy could prevent T cell exhaustion and boost immunotherapy
AI Summary

Researchers at Memorial Sloan Kettering Cancer Center have identified that the signaling molecule MEK contributes to T cell exhaustion in cancer patients. Blocking MEK could potentially extend the effectiveness of immunotherapy treatments.

by Jim Stallard, Memorial Sloan Kettering Cancer Center

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthscience

Get the full story

Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.

Create free account

Already have an account? Sign in